Dennis M Lanfear

CHRS

Dennis M Lanfear serves as President & CEO at Coherus Oncology, Inc. (CHRS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$871.0K

Net Position

Net Seller

$871.0K

Companies Traded

CHRS

Active Period

Jun 2021 – Nov 2023

2 total trades

Most Recent

Sell CHRS

Nov 24, 2023 · $449.8K

Dennis M Lanfear's Insider Trading at Coherus Oncology, Inc. (CHRS)

Buys

0 · $0.00

Sells

2 · $871.0K

Total Shares Bought

Total Shares Sold

254,154

CHRS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 24, 2023	Sell	223,100	$2.02	$449.8K	731,693
Jun 8, 2021	Sell	31,054	$13.56	$421.2K	493,258

Explore More Insider Trading Data

CHRS Insider Trading Activity

View all insider trades at Coherus Oncology, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity